Precigen
PGEN
#4281
Rank
C$3.96 B
Marketcap
C$11.13
Share price
2.76%
Change (1 day)
149.23%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): -C$0.22 Billion

According to Precigen's latest financial reports the company's current earnings are C$85.71 Million. In 2025 the company made an earning of -C$0.36 Billion a decrease over its 2024 earnings that were of -C$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.22 Billion-38.85%
2025 -C$0.36 Billion95.77%
2024 -C$0.19 Billion32.86%
2023 -C$0.14 Billion20.5%
2022 -C$0.12 Billion-23.33%
2021 -C$0.15 Billion60.11%
2020 -C$92.86 Million-65.1%
2019 -C$0.27 Billion-65.19%
2018 -C$0.77 Billion313.44%
2017 -C$0.19 Billion-33.2%
2016 -C$0.28 Billion123.22%
2015 -C$0.13 Billion1.47%
2014 -C$0.13 Billion109.54%
2013 -C$58.32 Million-50.04%
2012 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-C$3.55 Million-98.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-C$0.11 Billion-53.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-C$0.32 Billion 41.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-C$0.18 Billion-24.03% Jersey